| Literature DB >> 25049795 |
Sang-Hwan Kim1, Young-Seon Song1, Sue-Yun Hwang1, Kwan-Sik Min1, Jong-Taek Yoon1.
Abstract
Proteases and protease inhibitors play key roles in most physiological processes, including cell migration, cell signaling, and cell surface and tissue remodeling. Among these, the matrix metalloproteinase (MMPs) pathway is one of the most efficient biosynthetic pathways for controlling the activation of enzymes responsible for protein degradation. This also indicates the association of MMPs with the maturation of spermatozoa. In an attempt to investigate the effect of MMP activation and inhibitors in cultures with various hormones during sperm capacitation, we examined and monitored the localization and expression of MMPs (MMP-2 and MMP-9), tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3), as well as their expression profiles. Matured spermatozoa were collected from cultures with follicle-stimulating hormone (FSH), luteinizing hormone (LH), and Lutalyse at 1 h, 6 h, 18 h, and 24 h. ELISA detected the expression of MMP-2, MMP-9, TIMP-2, and TIMP-3 in all culture media, regardless of medium type (FSH-supplemented fertilization Brackett-Oliphant medium (FFBO), LH-supplemented FBO (LFBO), or Lutalyse-supplemented FBO (LuFBO)). TIMP-2 and TIMP-3 expression patterns decreased in LFBO and LuFBO. MMP-2 and MMP-9 activity in FBO and FFBO progressively increased from 1 h to 24 h but was not detected in LFBO and LuFBO. The localization and expression of TIMP-2 and TIMP-3 in sperm heads was also measured by immunofluorescence analysis. However, MMPs were not detected in the sperm heads. MMP and TIMP expression patterns differed according to the effect of various hormones. These findings suggest that MMPs have a role in sperm viability during capacitation. In conjunction with hormones, MMPs play a role in maintaining capacitation and fertilization by controlling extracellular matrix inhibitors of sperm.Entities:
Keywords: Bovine; Capacitation; MMPs; Spermatozoa; TIMPs
Year: 2013 PMID: 25049795 PMCID: PMC4093475 DOI: 10.5713/ajas.2012.12564
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Figure 1.Effect of different hormones treated for survival ability spermatozoa and acrosome reacted under hormones culture for 1, 6, 18 and 24 h. *,** Different letters within the same column represent a significant difference (p<0.05). Black arrows indicate normal acrosome detection. And white arrows indicate abnormal acrosome detection. A: Hoechst33258 analysis of sperm viability under hormones culture for 1, 6, 18 and 24 h. Stained spermatozoa were considered dead and the unstained alive. (Graph of survival ability spermatozoa), B: Effects of hormones on acrosome morphology spermatozoa culture for 6, 18 and 24 h, B-a: Percentage of acrosome morphology. FBO: Control, FFBO: FSH treated culture medium, LFBO: LH treated culture medium, LuFBO: Lutalyse treated culture medium.
Figure 3.ELISA analysis of MMP-2, 9 and TIMP-2, 3 in bovine sperm conditioned media collected at 1, 6, 18 and 24 h of culture. Normal: FBO control, FFBO: FSH treatment, LFBO: LH treatment, LuFBO: Lutalyse treatment.
Figure 2.Protein profile and MMPs activity analyzed of cultured medium and bovine spermatozoa protein. A: Protein profile during FBO and hormone treatment in sperm and culture medium. A-1: Culture mediums. FBO control: (Lane 1. 1 h, Lane 2. 6 h, Lane 3. 18 h, Lane 4. 24 h), FSH treatment: (Lane 5. 1 h, Lane 6. 6 h, Lane 7. 18 h, Lane 8. 24 h), LH treatment: (Lane 9. 1 h, Lane 10. 6 h, Lane 11. 18 h, Lane 12. 24 h), Lutalyse treatment (Lane 13. 1 h, Lane 14. 6 h, Lane 15. 18 h, Lane 16. 24 h). A-2: Sperm proteins. FBO control: (Lane 1. 1 h, Lane 2. 6 h, Lane 3. 18 h, Lane 4. 24 h), FSH treatment: (Lane 5. 1 h, Lane 6. 6 h, Lane 7. 18 h, Lane 8. 24 h), LH treatment: (Lane 9. 1 h, Lane 10. 6 h, Lane 11. 18 h, Lane 12. 24 h), Lutalyse treatment (Lane 13. 1 h, Lane 14. 6 h, Lane 15. 18 h, Lane 16. 24 h). B: Zymograms of MMP activities in bovine sperm conditioned media collected at 1,6,18 and 24 h of culture. B-1: Non treatment group: (Lane 1. 1 h, Lane 2. 6 h, Lane 3. 18 h, Lane 4. 24 h), B-2: Activity MMP2,9 analysis during FBO & FSH treatment. FBO control: (Lane 1. 1 h, Lane 2. 6 h, Lane 3. 18 h, Lane 4. 24 h) FSH treatment: (Lane 5. 1 h, Lane 6. 6 h, Lane 7. 18 h, Lane 8. 24 h) B-3: Activity MMP2,9 analysis during LFBO and FSH treatment. LH treatment: (Lane 1. 1 h, Lane 2. 6 h, Lane 3. 18 h, Lane 4. 24 h). Lutalyse treatment: (Lane 5. 1 h, Lane 6. 6h, Lane 7. 18h, Lane 8. 24 h).
Figure 4.Expression and localization of TIMP-2,3 protein in bovine sperm. White arrows indicate aTIMP-2 and 3 protein detection. A: Immuno-localization of TIMP-2,3 protein in spermatozoa. A-1: TIMP-2, A-2: TIMP-3. B: Western-blot of TIMP-2, 3. C: Immunofluorescence for TIMP-3 localization in sperm. C-1: TIMP-2, C-2: TIMP-3.